Measurable disease per FET-PET vs MRI in GBM

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Nathalie Albert

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.

Episode metadata supplied by the publisher feed · Published Feb 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Measurable disease per FET-PET vs MRI in GBM

0:00 14:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 14 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on February 8, 2025.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!